Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomas

被引:70
作者
Ponzoni, M.
Berger, F.
Chassagne-Clement, C.
Tinguely, M.
Jouvet, A.
Ferreri, A. J. M.
Dell'Oro, S.
Terreni, M. R.
Doglioni, C.
Weis, J.
Cerati, M.
Milani, M.
Iuzzolino, P.
Motta, T.
Carbone, A.
Pedrinis, E.
Sanchez, J.
Blay, J.-Y.
Reni, M.
Conconi, A.
Bertoni, F.
Zucca, E.
Cavalli, F.
Borisch, B.
机构
[1] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland
[2] Ist Sci San Raffaele, Pathol Unit, I-20132 Milan, Italy
[3] Ist Sci San Raffaele, Unit Lymphoid Malignacies, Pathol Unit, Milan, Italy
[4] Ctr Hosp Lyon Sud, Dept Pathol, Lyon, France
[5] Ctr Leon Berard, Dept Pathol, F-69373 Lyon, France
[6] Hop Cantonal Univ Geneva, Pathol Clin, Geneva, Switzerland
[7] Ist Sci San Raffaele, Unit Lymphoid Malignancies, Med Oncol Unit, Milan, Italy
[8] Univ Bern, Inselspital, Dept Pathol, CH-3010 Bern, Switzerland
[9] Osped Circolo Fdn Macchi, Dept Pathol, Varese, Italy
[10] Azienda Osped Lecco, Dept Pathol, Verona, Italy
[11] Osped Riuniti Bergamo, Dept Pathol, I-24100 Bergamo, Italy
[12] Natl Canc Inst, Dept Pathol, Aviano, Italy
[13] Inst Pathol, Locarno, Switzerland
[14] Inst Enfermadades Neoplast, Lima, Peru
[15] Ctr Leon Berard, Unit Cytokines & Canc, F-69373 Lyon, France
[16] Osped Circolo Fdn Macchi, Dept Radiotherapy, Varese, Italy
[17] Osped San Giovanni Bellinzona, Ist Oncol Svizzera Italiana, Bellinzona, Switzerland
关键词
brain; central nervous system; lymphoma; pathology; prognosis;
D O I
10.1111/j.1365-2141.2007.06661.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Well-established histopathological prognostic factors are lacking in primary central nervous system (CNS) lymphomas (PCNSL). The present study investigated the presence and prognostic role of tumour necrosis (TN) and reactive perivascular T-cell infiltrate (RPVI), defined as a rim of small reactive T-lymphocytes occurring alone or located between the vascular wall and large neoplastic cells, in tumour samples from 100 immunocompetent patients with PCNSL. World Health Organization histotypes of the patients were: 96 diffuse large B-cell lymphomas, two Burkitt-like lymphomas, one anaplastic large T-cell lymphoma and one unclassified B-cell lymphoma. TN was observed in 24 (24%) cases and RPVI in 26 (36%) of 73 assessable cases. Patients with RPVI-positive lesions exhibited a significantly better overall survival (OS) than patients with RPVI-negative lymphoma, particularly among patients treated with high-dose methotrexate-based chemotherapy (3-year OS: 59 +/- 14% vs. 42 +/- 9%, P = 0.02). By contrast, the presence of TN did not demonstrate prognostic significance. Multivariate analysis confirmed an independent association between RPVI and survival. In conclusion, the presence of RPVI is independently associated with survival in PCNSL. This parameter can be easily and routinely assessed at diagnosis on histopathological specimens.
引用
收藏
页码:316 / 323
页数:8
相关论文
共 24 条
[1]  
[Anonymous], 2004, HISTOPATHOLOGY NODAL
[2]   CD4+T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome [J].
Ansell, SM ;
Stenson, M ;
Habermann, TM ;
Jelinek, DF ;
Witzig, TE .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (03) :720-726
[3]   T-cell infiltration of primary CNS lymphoma [J].
Bashir, R ;
Chamberlain, M ;
Ruby, E ;
Hochberg, FH .
NEUROLOGY, 1996, 46 (02) :440-444
[4]  
Braaten KM, 2003, CLIN CANCER RES, V9, P1063
[5]   Primary central nervous system lymphomas in 72 immunocompetent patients pathologic findings and clinical correlations [J].
Camilleri-Broet, S ;
Martin, A ;
Moreau, A ;
Angonin, R ;
Hénin, D ;
Gontier, MF ;
Rousselet, MC ;
Caulet-Maugendre, S ;
Cuillière, P ;
Lefrancq, T ;
Mokhtari, K ;
Morcos, M ;
Broët, P ;
Kujas, N ;
Hauw, JJ ;
Desablens, B ;
Raphaël, M .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1998, 110 (05) :607-612
[6]   A uniform activated B-cell-like in-immunophenotype might explain the poor prognosis of primary central nervous system lymphomas:: analysis of 83 cases [J].
Camilleri-Broët, S ;
Crinière, E ;
Broët, P ;
Delwail, V ;
Mokhtari, K ;
Moreau, A ;
Kujas, M ;
Raphaël, M ;
Iraqi, W ;
Sautès-Fridman, C ;
Colombat, P ;
Hoang-Xuan, K ;
Martin, A .
BLOOD, 2006, 107 (01) :190-196
[7]  
Chang CC, 2003, ARCH PATHOL LAB MED, V127, P208
[8]   Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells [J].
Dave, SS ;
Wright, G ;
Tan, B ;
Rosenwald, A ;
Gascoyne, RD ;
Chan, WC ;
Fisher, RI ;
Braziel, RM ;
Rimsza, LM ;
Grogan, TM ;
Miller, TP ;
LeBlanc, M ;
Greiner, TC ;
Weisenburger, DD ;
Lynch, JC ;
Vose, J ;
Armitage, JO ;
Smeland, EB ;
Kvaloy, S ;
Holte, H ;
Delabie, J ;
Connors, JM ;
Lansdorp, PM ;
Ouyang, Q ;
Lister, TA ;
Davies, AJ ;
Norton, AJ ;
Muller-Hermelink, HK ;
Ott, G ;
Campo, E ;
Montserrat, E ;
Wilson, WH ;
Jaffe, ES ;
Simon, R ;
Yang, LM ;
Powell, J ;
Zhao, H ;
Goldschmidt, N ;
Chiorazzi, M ;
Staudt, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (21) :2159-2169
[9]   Prognostic scoring system for primary CNS lymphomas: The international extranodal lymphoma study group experience [J].
Ferreri, AJM ;
Blay, JY ;
Reni, M ;
Pasini, F ;
Spina, M ;
Ambrosetti, A ;
Calderoni, A ;
Rossi, A ;
Vavassori, V ;
Conconi, A ;
Devizzi, L ;
Berger, F ;
Ponzoni, M ;
Borisch, B ;
Tinguely, M ;
Cerati, M ;
Milani, M ;
Orvieto, E ;
Sanchez, J ;
Chevreau, C ;
Dell'Oro, S ;
Zucca, E ;
Cavalli, F .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (02) :266-272
[10]   A multicenter study of treatment of primary CNS lymphoma [J].
Ferreri, AJM ;
Reni, M ;
Pasini, F ;
Calderoni, A ;
Tirelli, U ;
Pivnik, A ;
Aondio, GM ;
Ferrarese, F ;
Gomez, H ;
Ponzoni, M ;
Borisch, B ;
Berger, F ;
Chassagne, C ;
Iuzzolino, P ;
Carbone, A ;
Weis, J ;
Pedrinis, E ;
Motta, T ;
Jouvet, A ;
Barbui, T ;
Cavalli, F ;
Blay, JY .
NEUROLOGY, 2002, 58 (10) :1513-1520